Security key
92829J203
Dogwood Therapeutics, Inc. - Common Stock, par value $0.0001 (DWTX)
CUSIP: 92829J203
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, par value $0.0001
- Total 13F shares
- 120
- Total 13F value
- $193
- Share change
- 0
- SEC-reported price per share
- $1.61
- Number of holders
- 1
- Shares outstanding
- 33,464,665
Holder snapshot
3 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
1
Top holders
1
DWTX full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
Dogwood Therapeutics, Inc. SEC filings
Dogwood Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92829J203
Recent filing periods:
Ownership snapshot
Top reported holders of DWTX - Dogwood Therapeutics, Inc. - Common Stock, par value $0.0001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Sealbond Ltd
Disclosed value leader
Sealbond Ltd
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G
3/4/5
13F
Lead comparable stake: 83%
13D/G row: Sealbond Ltd
Showing 1-6 of 15 holder rows.
Quick read
Sealbond Ltd leads the comparable SEC ownership view at 83%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Sealbond Ltd's linked filing trail.
Comparable ownership
Top 5
Sealbond Ltd
83%
ARMISTICE CAPITAL, LLC
10%
Orca Capital AG
3.7%
VANGUARD CAPITAL MANAGEMENT LLC
0.39%
GEODE CAPITAL MANAGEMENT, LLC
0.24%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Sealbond Ltd |
13D/G
3/4/5
CK Life Sciences Int'l., (Holdings) Inc. · Director, Other*, 10%+ Owner
|
83%
|
$164,022,057
24,664,971 shares
|
+$162,616,360 | 21 Nov 2025 |
| ARMISTICE CAPITAL, LLC |
13D/G
13F
Company
|
10%
|
$7,053,983
3,343,120 shares
|
$0 | 31 Mar 2026 |
| Orca Capital AG |
13D/G
|
3.7%
|
$390,299
69,821 shares
|
-$256,967 | 14 Mar 2025 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
0.39%
|
$278,845
132,154 shares
|
— | 31 Mar 2026 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.24%
|
$167,608
79,434 shares
|
— | 31 Mar 2026 |
| VANGUARD FIDUCIARY TRUST CO |
13F
Company
|
0.19%
|
$132,373
62,736 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
120
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
13
Q2 2026 holders
1
Holder diff
-12
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend